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Background
The incidence of TE events in IBD patients is higher
than in population control [1,2].
The main reason for this, is the hypercoaugulable state
[3,4].
Our aim was to detect serum markers related to TE,
that can assume preventing and prognostic meanings.
Materials and methods
We performed a 3 year study on 71 patients with IBD,
evaluating hypercoaugulability, and then we compared
the results with 71 patients non IBD group control.
We also investigated patients of both groups concerning
TE events occurred already.
Results
In IBD group we found out that 16 patients (22.5%) had
a history of TE versus >1% of group control.
19 of them, already had knowledge of their previous
hypercoaugulating condition.
48 (67%) had increased markers value versus less then
6% detected in group control.
In IBD group 43% ,20% and 4.2% had respectively 1,
1-3 or > 3 markers higher levels then normal range.
Among the markers investigated, we detected
increased levels of plated in 33%, homocysteine in
26.7%, d-dimero 25.3%, c3 in 15.4%, apcr in 5.6%.
Conclusions
From our study we detected a higher incidence of TE
events, and hypercoaugulating status in IBD group. In
our previous investigations, plated, homocysteine,
d-dimero, c3, and apcr, seemed to be the TE markers
with higher sensibility.
It seems reasonable, according our experience, to pro-
pose a new TE risk score index for IBD patients:
low, mild and high risk respectively for patients with
1, 1-3 and >3 markers with higher serum levels then
normal range.
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